Evidence map›Paper›PMID 26669675›Full record

ArticleJournal of neuroinflammation2015

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.

L Schrewe, C M Lill, T Liu, A Salmen, L A Gerdes, L Guillot-Noel, D A Akkad, P Blaschke, C Graetz, S Hoffjan and 16 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 14 institutions in 4 countries.

L SchreweDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, 44791, Germany. lisa.schrewe@rub.de.
C M LillPlatform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany. lill@molgen.mpg.de.
T LiuMax Planck Institute for Human Development, Berlin, Germany. tianliu@mpib-berlin.mpg.de.
A SalmenDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, 44791, Germany. anke.salmen@rub.de.
L A GerdesInstitute for Clinical Neuroimmunology, Medical Campus Grosshadern, Ludwig Maximilian University, Munich, Germany. LisaAnn.Gerdes@med.uni-muenchen.de.
L Guillot-NoelInserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France. lena.guillot-noel@upmc.fr.
D A AkkadDepartment of Human Genetics, Ruhr-University Bochum, Bochum, Germany. Amer.Akkad@rub.de.
P BlaschkeDepartment of Neurology, University of Rostock, Rostock, Germany. paul.blaschke@uni-rostock.de.
C GraetzDepartment of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Christiane.Graetz@unimedizin-mainz.de.
S HoffjanDepartment of Human Genetics, Ruhr-University Bochum, Bochum, Germany. Sabine.Hoffjan@rub.de.
A KronerCentre for Research in Neuroscience, The Research Institute of the McGill University Health Center, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada. antje.kroner@gmail.com.
S DemirDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, 44791, Germany. seray.demir@rub.de.
A BöhmeDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, 44791, Germany. anne.boehme@rub.de.
P RieckmannDepartment of Neurology, University of Würzburg, Würzburg, Germany. peter.rieckmann@sozialstiftung-bamberg.de.
A ElAliNeuroscience Axis, Research Center of CHU de Québec-CHUL, Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University, Québec City, QC, Canada. ayman.el-ali@crchuq.ulaval.ca.
N HagemannDepartment of Vascular Neurology and Dementia, University of Duisburg-Essen, Essen, Germany. Nina.Hagemann@uk-essen.de.
D M HermannDepartment of Vascular Neurology and Dementia, University of Duisburg-Essen, Essen, Germany. Dirk.Hermann@uk-essen.de.
I Cournu-RebeixInserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France. isabelle.rebeix@upmc.fr.
F ZippDepartment of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. frauke.zipp@unimedizin-mainz.de.
T KümpfelInstitute for Clinical Neuroimmunology, Medical Campus Grosshadern, Ludwig Maximilian University, Munich, Germany. Tania.Kuempfel@med.uni-muenchen.de.
M ButtmannDepartment of Neurology, University of Würzburg, Würzburg, Germany. m.buttmann@uni-wuerzburg.de.
U K ZettlDepartment of Neurology, University of Rostock, Rostock, Germany. uwe.zettl@med.uni-rostock.de.
B FontaineInserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France. bertrand.fontaine@upmc.fr.
L BertramPlatform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany. lbertram@molgen.mpg.de.
R GoldDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, 44791, Germany. ralf.gold@rub.de.
A ChanDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, 44791, Germany. Andrew.chan@rub.de.
Ruhr University Bochum · DEInserm · FRLudwig-Maximilians-Universität München · DEUniversity of Duisburg-Essen · DEUniversity of Rostock · DEUniversity of Würzburg · DECentre National de la Recherche Scientifique · FRImperial College London · GBInstitute for Integrative and Experimental Genomics · DEJohannes Gutenberg University Mainz · DEMax Planck Institute for Human Development · DEMcGill University Health Centre · CAUniversité Laval · CAUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite pleiotropic immunomodulatory effects of apolipoprotein E (apoE) in vitro, its effects on the clinical course of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS) are still controversial. As sex hormones modify immunomodulatory apoE functions, they may explain contentious findings. This study aimed to investigate sex-specific effects of apoE on disease course of EAE and MS.

methodsMOG(35-55) induced EAE in female and male apoE-deficient mice was assessed clinically and histopathologically. apoE expression was investigated by qPCR. The association of the MS severity score (MSSS) and APOE rs429358 and rs7412 was assessed across 3237 MS patients using linear regression analyses.

resultsEAE disease course was slightly attenuated in male apoE-deficient (apoE (-/-) ) mice compared to wildtype mice (cumulative median score: apoE (-/-)  = 2 [IQR 0.0-4.5]; wildtype = 4 [IQR 1.0-5.0]; n = 10 each group, p = 0.0002). In contrast, EAE was more severe in female apoE (-/-) mice compared to wildtype mice (cumulative median score: apoE (-/-)  = 3 [IQR 2.0-4.5]; wildtype = 3 [IQR 0.0-4.0]; n = 10, p = 0.003). In wildtype animals, apoE expression during the chronic EAE phase was increased in both females and males (in comparison to naïve animals; p < 0.001). However, in MS, we did not observe a significant association between MSSS and rs429358 or rs7412, neither in the overall analyses nor upon stratification for sex.

conclusionsapoE exerts moderate sex-specific effects on EAE severity. However, the results in the apoE knock-out model are not comparable to effects of polymorphic variants in the human APOE gene, thus pinpointing the challenge of translating findings from the EAE model to the human disease.

Indexed as

AnimalsApolipoproteins EEncephalomyelitis, Autoimmune, ExperimentalFemaleFluorescent Antibody TechniqueGenotypeHumansMaleMiceMice, Inbred C57BLMice, KnockoutMultiple SclerosisReal-Time Polymerase Chain ReactionSex FactorsApolipoproteins E

Identifiers

PMID26669675
PMCPMC4681148
OpenAlexW2213731036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.